Exane Derivatives Avantor, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Avantor, Inc. stock. As of the latest transaction made, Exane Derivatives holds 36 shares of AVTR stock, worth $768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36
Previous 36
-0.0%
Holding current value
$768
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AVTR
# of Institutions
573Shares Held
645MCall Options Held
2.47MPut Options Held
8.7M-
Dodge & Cox San Francisco, CA68.4MShares$1.46 Billion1.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD67.1MShares$1.43 Billion1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA62.8MShares$1.34 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY44MShares$940 Million0.02% of portfolio
-
State Street Corp Boston, MA22.4MShares$478 Million0.02% of portfolio
About Avantor, Inc.
- Ticker AVTR
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 674,035,008
- Market Cap $14.4B
- Description
- Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...